BACKGROUND: Recent studies have called into question the benefit of perioperative corticosteroids in children undergoing heart surgery, but have been limited by the lack of placebo control, limited power, and grouping of various steroid regimens together in analysis. We evaluated outcomes across methylprednisolone regimens versus no steroids in a large cohort of neonates. METHODS: Clinical data from the Society of Thoracic Surgeons Database were linked to medication data from the Pediatric Health Information Systems Database for neonates (≤30 days) undergoing heart surgery (2004-2008) at 25 participating centers. Multivariable analysis adjusting for patient and center characteristics, surgical risk category, and within-center clustering was used to evaluate the association of methylprednisolone regimen with outcome. RESULTS: A total of 3180 neonates were included: 22% received methylprednisolone on both the day before and day of surgery, 12% on the day before surgery only, and 28% on the day of surgery only; 38% did not receive any perioperative steroids. In multivariable analysis, there was no significant mortality or length-of-stay benefit associated with any methylprednisolone regimen versus no steroids, and no difference in postoperative infection. In subgroup analysis by surgical-risk group, there was a significant association of methylprednisolone with infection consistent across all regimens (overall odds ratio 2.6, 95% confidence interval 1.3-5.2) in the lower-surgical-risk group. CONCLUSIONS: This multicenter observational analysis did not find any benefit associated with methylprednisolone in neonates undergoing heart surgery and suggested increased infection in certain subgroups. These data reinforce the need for a large randomized trial in this population.
BACKGROUND: Recent studies have called into question the benefit of perioperative corticosteroids in children undergoing heart surgery, but have been limited by the lack of placebo control, limited power, and grouping of various steroid regimens together in analysis. We evaluated outcomes across methylprednisolone regimens versus no steroids in a large cohort of neonates. METHODS: Clinical data from the Society of Thoracic Surgeons Database were linked to medication data from the Pediatric Health Information Systems Database for neonates (≤30 days) undergoing heart surgery (2004-2008) at 25 participating centers. Multivariable analysis adjusting for patient and center characteristics, surgical risk category, and within-center clustering was used to evaluate the association of methylprednisolone regimen with outcome. RESULTS: A total of 3180 neonates were included: 22% received methylprednisolone on both the day before and day of surgery, 12% on the day before surgery only, and 28% on the day of surgery only; 38% did not receive any perioperative steroids. In multivariable analysis, there was no significant mortality or length-of-stay benefit associated with any methylprednisolone regimen versus no steroids, and no difference in postoperative infection. In subgroup analysis by surgical-risk group, there was a significant association of methylprednisolone with infection consistent across all regimens (overall odds ratio 2.6, 95% confidence interval 1.3-5.2) in the lower-surgical-risk group. CONCLUSIONS: This multicenter observational analysis did not find any benefit associated with methylprednisolone in neonates undergoing heart surgery and suggested increased infection in certain subgroups. These data reinforce the need for a large randomized trial in this population.
Authors: N J Jansen; W van Oeveren; M van Vliet; C P Stoutenbeek; L Eysman; C R Wildevuur Journal: Eur J Cardiothorac Surg Date: 1991 Impact factor: 4.191
Authors: Sean M O'Brien; David R Clarke; Jeffrey P Jacobs; Marshall L Jacobs; Francois G Lacour-Gayet; Christian Pizarro; Karl F Welke; Bohdan Maruszewski; Zdzislaw Tobota; Weldon J Miller; Leslie Hamilton; Eric D Peterson; Constantine Mavroudis; Fred H Edwards Journal: J Thorac Cardiovasc Surg Date: 2009-11 Impact factor: 5.209
Authors: David R Clarke; Linda S Breen; Marshall L Jacobs; Rodney C G Franklin; Zdzislaw Tobota; Bohdan Maruszewski; Jeffrey P Jacobs Journal: Cardiol Young Date: 2008-12 Impact factor: 1.093
Authors: Katherine E Bates; Nicolas L Madsen; Lara Khadr; Zhiqian Gao; Kari Crawford; Michael Gaies; Margaret Graupe; Samuel P Hanke; Anthony M Hlavacek; Evonne Morell; Sara K Pasquali; Jennifer L Russell; Susan K Schachtner; Ronn E Tanel; Adam L Ware; Alaina K Kipps Journal: Ann Thorac Surg Date: 2019-11-21 Impact factor: 4.330
Authors: David W Jantzen; Xia He; Jeffrey P Jacobs; Marshall L Jacobs; Michael G Gaies; Matt Hall; John E Mayer; Samir S Shah; Jennifer Hirsch-Romano; J William Gaynor; Eric D Peterson; Sara K Pasquali Journal: World J Pediatr Congenit Heart Surg Date: 2014-07
Authors: Sara K Pasquali; Marshall L Jacobs; Xia He; Samir S Shah; Eric D Peterson; Matthew Hall; J William Gaynor; Kevin D Hill; John E Mayer; Jeffrey P Jacobs; Jennifer S Li Journal: Pediatrics Date: 2014-02-24 Impact factor: 7.124
Authors: Sara K Pasquali; Xia He; Jeffrey P Jacobs; Marshall L Jacobs; Michael G Gaies; Samir S Shah; Matthew Hall; J William Gaynor; Eric D Peterson; John E Mayer; Jennifer C Hirsch-Romano Journal: Ann Thorac Surg Date: 2015-01-24 Impact factor: 4.330
Authors: Kenneth E Mah; Shiying Hao; Scott M Sutherland; David M Kwiatkowski; David M Axelrod; Christopher S Almond; Catherine D Krawczeski; Andrew Y Shin Journal: Pediatr Nephrol Date: 2017-11-11 Impact factor: 3.714
Authors: Sara K Pasquali; Jeffrey P Jacobs; Edward L Bove; J William Gaynor; Xia He; Michael G Gaies; Jennifer C Hirsch-Romano; John E Mayer; Eric D Peterson; Nelangi M Pinto; Samir S Shah; Matt Hall; Marshall L Jacobs Journal: Ann Thorac Surg Date: 2015-07-14 Impact factor: 4.330
Authors: Eric M Graham; Reneé H Martin; Jason R Buckley; Sinai C Zyblewski; Minoo N Kavarana; Scott M Bradley; Bahaaldin Alsoufi; William T Mahle; Marc Hassid; Andrew M Atz Journal: J Am Coll Cardiol Date: 2019-08-06 Impact factor: 24.094